[
  {
    "ts": null,
    "headline": "TECH Q4 Deep Dive: Margin Expansion and Flat Revenue Amid Mixed End Markets",
    "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $295.9 million. Its non-GAAP profit of $0.46 per share was 5.8% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=6dc57a11b652918dbe8d1057343e4f9fa6886c96a9edb18f9c93f1e60a2b11ba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770269678,
      "headline": "TECH Q4 Deep Dive: Margin Expansion and Flat Revenue Amid Mixed End Markets",
      "id": 138362878,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $295.9 million. Its non-GAAP profit of $0.46 per share was 5.8% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=6dc57a11b652918dbe8d1057343e4f9fa6886c96a9edb18f9c93f1e60a2b11ba"
    }
  }
]